and mitochondrial Cx43 play distinct roles: formation of gap junctions and production of reactive oxygen species (ROS) for redox signaling. In this study, we examined the hypothesis that Cx43 contributes to activation of a major cytoprotective signal pathway, phosphoinositide 3-kinase (PI3K)-Akt-glycogen synthase kinase-3␤ (GSK-3␤) signaling, in cardiomyocytes. A ␦-opioid receptor agonist {[D-Ala 2 ,DLeu 5 ]enkephalin acetate (DADLE)}, endothelin-1 (ET-1), and insulin-like growth factor-1 (IGF-1) induced phosphorylation of Akt and GSK-3␤ in H9c2 cardiomyocytes. Reduction of Cx43 protein to 20% of the normal level by Cx43 small interfering RNA abolished phosphorylation of Akt and GSK-3␤ induced by DADLE or ET-1 but not that induced by IGF-1. DADLE and IGF-1 protected H9c2 cells from necrosis after treatment with H 2O2 or antimycin A. The protection by DADLE or ET-1, but not that by IGF-1, was lost by reduction of Cx43 protein expression. In contrast to Akt and GSK-3␤, PKC-ε, ERK and p38 mitogen-activated protein kinase were phosphorylated by ET-1 in Cx43-knocked-down cells. Like diazoxide, an activator of the mitochondrial ATP-sensitive K ϩ channel, DADLE and ET-1 induced significant ROS production in mitochondria, although such an effect was not observed for IGF-1. Cx43 knockdown did not attenuate the mitochondrial ROS production by DADLE or ET-1. Cx43 was coimmunoprecipitated with the ␤-subunit of G protein (G␤), and knockdown of G␤ mimicked the effect of Cx43 knockdown on ET-1-induced phosphorylation of Akt and GSK-3␤. These results suggest that Cx43 contributes to activation of class I B PI3K in PI3K-Akt-GSK-3␤ signaling possibly as a cofactor of G␤ in cardiomyocytes. mitochondria; G-protein-coupled receptor; insulin-like growth factor-1; reactive oxygen species; phosphoinositide 3-kinase; glycogen synthase kinase-3␤
CONNEXIN-43 (CX43) IS A MAJOR subunit protein of gap junctions in the ventricular myocardium, and its phosphorylation at Ser or Tyr residues by protein kinases is one of regulatory mechanisms of gap junction permeability (20, 34) . The number of gap junctions and conductance of each gap junction determine electrical coupling of cardiomyocytes in the heart. However, in addition to its role as a subunit of gap junctions, Cx43 plays various roles in cell survival and death, depending on circumstances and cell types (9, 20) . An important role of Cx43 in production of reactive oxygen species (ROS) in mitochondria for redox signaling has been demonstrated by a series of earlier studies (4, 15, 18, 30) . In addition, Cx43 hemichannels in the cell membrane were recently suggested to be involved in signal transduction by receptors and signaling molecules such as the P2Y1 receptor and AGS8 (activator of G-protein signaling 8; Refs. 12, 32, 33) .
Of signaling pathways functioning for cytoprotection, phosphoinositide 3-kinase (PI3K)-Akt-glycogen synthase kinase-3␤ (GSK-3␤) signaling is a major one, being involved in protection of different types of cells from necrosis and apoptosis (19, 21) . In the myocardium, this signaling plays a crucial role in anti-infarct tolerance afforded by insulin, erythropoietin, bradykinin, adenosine receptor agonists, preconditioning, and also postconditioning (6, 11, 14, 22, 27, 28, 38, 40) . Studies by Oldenburg et al. (24, 25) and by Krieg et al. (17) indicated that PI3K-Akt signaling activates production of reactive oxygen species (ROS) by opening of the mitochondrial ATP-sensitive K ϩ channel (mK ATP channel) and this function of the mK ATP channel requires a certain level of Cx43 protein in mitochondria (15, 30) . However, the role of Cx43 in PI3K-Akt-GSK-3␤ signaling has not been systematically examined.
In the present study, we examined whether Cx43 plays an indispensable role in the PI3K-Akt-GSK-3␤ signal pathway in cardiomyocytes and whether its role, if any, is played by mitochondrial Cx43 or sarcolemmal Cx43. Since both class I A and class I B PI3Ks are coupled with Akt-GSK-3␤ signaling in cardiomyocytyes, we compared the effects of stimulation of a cytokine receptor, insulin-like growth factor-1 (IGF-1) receptor, with the effects of stimulation of G-protein-coupled receptors (GPCRs). The function of mitochondrial Cx43 was assessed by monitoring mitochondrial ROS production using Mito Tracker Red fluorescence as an indicator. Involvement of Cx43 in the signal transduction was examined by knocking down Cx43 protein expression and by immunoprecipitation of Cx43 with signaling molecules. Results of the experiments indicated that Cx43 contributes to activation of Akt-GSK-3␤ signaling by class I B PI3K possibly via its interaction with the ␤-subunit of G-protein (G␤) but not via production of mitochondrial ROS.
METHODS
This study was approved by the Animal Research Ethics Committee of Sapporo Medical University.
Cell culture. H9c2 cells (rat cardiomyoblast cell line) and A7r5 cells (rat aortic smooth muscle cell line) were cultured in DMEM (Sigma, St. Louis, MO) supplemented with 10% FBS at 37°C with 5% CO 2. The cells were used for experiments when they were 70ϳ80% confluent, and FBS was removed from the medium 24 h before pharmacological treatments and/or induction of cell death.
Activation of GPCRs and IGF-1 receptor. To activate PI3K-Akt-GSK-3␤ signaling, H9c2 cells were treated with 300 nM [D-Ala 2 ,
D-Leu of cell lysates. The doses of these receptor agonists were selected on the basis of results of preliminary experiments using 300ϳ1,000 nM DADLE, 1ϳ100 nM ET-1, and 1ϳ10 nM IGF-1 and results of our previous studies (20, 23) . Cells that received vehicles served as controls.
Immunoblotting and immunoprecipitation. Whole cell lysates of H9c2 cells were prepared by using CellLytic-M mammalian cell lysis/extraction agent (Sigma). In some experiments, mitochondrial and cytosolic fractions or sarcolemma-rich fractions and cytosolic fractions were separated by a mitochondrial isolation kit (Pierce Biotechnology, Rockford, IL) or by a plasma membrane protein extraction kit (Abcam, Cambridge, MA), respectively. The samples were electrophoresed in 12.5% SDS-polyacrylamide gels and electroblotted onto polyvinylidene difluoride membranes. Proteins were visualized by use of antibodies against each protein of interest and Immobilon (Millipore, Bedford, MA). Protein levels were determined by a lumino-image analyzer (LAS-3000; Fujifilm, Tokyo, Japan). As primary antibodies for immunoblotting, antibodies against Akt, GSK-3␤, extracellular signal-regulated protein kinase (ERK), Ser473-phospho-Akt, Ser9-phospho-GSK-3␤, Thr202/Tyr204-phospho-ERK, protein kinase C-ε (PKC-ε), p38 mitogen-activated protein kinase (p38 MAP kinase), Thr180/Tyr182-phospho-p38 MAP kinase (Cell Signaling Technology, Beverly, MA), Ser729-phospho-PKC-ε (Upstate, Lake Placid, NY), G␤, GAPDH, Na ϩ -K ϩ -ATPase (Santa Cruz Biotechnology, Santa Cruz, CA), p110␥ subunit of PI3K (#5405, Cell Signaling; sc-7177, Santa Cruz Biotechnology), Cx43 (C6219; Sigma), Cx40 and Cx45 (nos. AB1726 and AB1745; Millipore, Billerica, MA) were used. For immunoprecipitation of Cx43, antibody no. 610062 (BD Biosciences, Sparks, MD) was used. Immunoprecipitation of Cx43, G␤, or p110␥ was performed using 400 g proteins as previously reported (20) .
Suppression of protein expression by small interfering RNA methods. H9c2 cells were transfected with small interfering (si)RNAs using the Cell Line Nucleofector Kit L (Amaxa, Gaithersburg, MD) 48 h before experiments in which responses of signaling pathways were examined by use of receptor agonists. The sense and antisense siRNAs in the cocktail were as follows: CAAGCAAGCUAGCGAGCAATT/ UUGCUCGCUAGCUUGCUUGTT, CUGAUGACCUGGAGAU-UUATT/UAAAUCUCCAGGUCAUCAGTT, and GCGAUAGCUUU-GAGCAGAATT/UUCUGCUCAAAGCUAUCGCTT for Cx43; GCU-GUUUGACCUUCGUGCATT/UGCACGAAGGUCAAACAGCTT and CUCAUGUAUUCCCACGACATT/UGUCGUGGGAAUACAU-GAGTT for G␤ (G␤1 and G␤2); CUUAGUAAGGCCAGCAGCATT/ UGCUGCUGGCUUACUAATT for Cx40; and CAUCUACUAUGAU-GAGCATT/UUGCUAUCAUAGUAGAUGTT for Cx45.
Quantitative real-time RT-PCR. Cells were lysed and mRNA was extracted by using an RNeasy Mini kit (Qiagen, Germantown, MD) according to the manufacturer's instructions. First-strand cDNA was synthesized using SuperScript III (Invitrogen, Carsbad, CA). Quantitative real-time RT-PCR analysis was performed for determination of mRNA levels of Cx45 with a StepOne (Applied Biosystems, Foster City, CA) using the Power SYBR Green Mater Mix. The following primer sequences were used: for Cx45, 5=-AAAGAGCAGAGC-CAACCAAA-3= and 5=-CCCACCTCAAACACAGTCCT-3=; and for GAPDH, 5=-TCACCACCATGGAGAAGGC-3=and 5=-GCTAAGC-AGTTGGTGGTGCA-3=. The thermal cycler conditions were as follows: hold for 10 min at 95°C and then by two-step PCR for 40 cycles of 95°C for 15 s followed by 60°C for 1 min. All assays were performed in duplicate. Differences between mRNA levels in study groups were examined by the comparative Ct method using endogenous GAPDH as an internal control.
Immunocytochemistry. Cells were cultured on collagen-coated glass dishes and were stained with 0.2 M Mito-Tracker Red for 15 min. Stained cells were then fixed with 4% paraformaldehyde, washed with PBS, blocked with 3% BSA in PBS for 30 min, and incubated in PBS containing 3% BSA and anti-Cx43 antibodies.
Determination of mitochondrial ROS production. The level of mitochondrial ROS production in H9c2 cells was determined by using MitoTracker Red as previously reported (17, 23) . H9c2 cells were treated with a vehicle, 300 nM DADLE, 10 nM ET-1, or 100 M diazoxide (an mK ATP channel opener) and 1 M MitoTracker Red for 15 min. Cells were then washed with the medium without MitoTracker Red. With the use of a fluorescent microscope, level of MitoTracker Red fluorescence of Ն40 cells in each well was determined and then averaged for each experiment. Control cells (i.e., control siRNA-transfected and vehicle-treated cells) were always included in each culture plate, and the fluorescent level in control cells was used to normalize values in the other treatment groups in the same plate.
Induction of cell necrosis. H9c2 cells were incubated with 100 M H 2O2 or 60 M antimyicin A for 3 h. Doses of the two agents were selected to induce different levels of necrosis (see RESULTS). One hour before addition of H 2O2 or antimycin A, cells were pretreated with DADLE, ET-1, IGF-1, or vehicle. At the end of the experiments, cells were fixed and stained with propidium iodide. More than 400 cells in each well were counted, and the percentage of cells with a propidium iodide-positive nucleus was determined as an index of cell necrosis. 
Blockade of Cx43 hemichannels and gap junctions.
To examine the effects of blockade of Cx43 hemichannels and gap junctions on protein kinase activation by GPCRs, H9c2 cells were incubated with an inhibitor of Cx43 channels, 37 ,43 GAP27 (Sigma; Ref. 8) , for 1 h before treatment with ET-1 or its vehicle. Cell lysates were prepared at 5 min after the treatment for immnoblotting.
Statistical analysis. Results are presented as means Ϯ SE. Differences between groups were tested by one-way or two-way ANOVA, and the Student-Newman-Keuls post hoc test was used for multiple comparisons when ANOVA indicated significant differences. Differences were considered significant when P was Ͻ0.05.
RESULTS
Effects of siRNA knockdown of Cx43 and G␤ on PI3K-Akt-GSK-3␤ signaling. Transfection of Cx43 siRNA reduced Cx43 protein by ϳ80%, and Cx43 levels in the mitochondrial and cytosolic fractions were similarly reduced (Fig. 1A) . Costaining of mitochondria and Cx43 confirmed that Cx43 siRNA suppressed Cx43 expression in mitochondria and other compartments in the cell (Fig. 1B) . Significant phosphorylation of Akt and GSK-3␤ was induced by DADLE, ET-1, or IGF-1 as shown in Figs. 2 and 3. Cx43 knockdown attenuated Akt-and GSK-3␤ phosphorylation after treatment with DADLE or ET-1 (Fig. 2) . However, phosphorylation of the kinases in response to IGF-1 was preserved (Fig. 3, A and B) . Inhibition of Jak2 by AG490 inhibited Akt phosphorylation induced by IGF-1 (Fig. 3C) . In contrast to Akt phosporylation induced by DADLE and ET-1 (Fig. 2) , IGF-1-induced phosphorylation of Akt was accompanied by reduction of total Akt protein level (Fig. 3, A and C) .
In whole lysates of untreated H9c2 cells, Cx43 was coimmunoprecipitated with G␤ (Fig. 4A) , although interaction of Cx43 with p110␥ of PI3K could not be examined since the anti-p110␥ we used did not work for immunoprecipitation in our hands (data not shown). To confirm interaction of Cx43 with G␤ in the membrane, we prepared sarcolemma-rich fractions and imunoprecipitated G␤. As shown in Fig. 4B , the Cx43 signal was detected in G␤ immunoprecipitates from sarcolemma-rich fractions. Similar to Cx43 knockdown, knockdown of G␤ (G␤1 and G␤2) abolished phosphorylation of Akt and GSK-3␤ by ET-1 (Fig. 4, C and D) . However, phosphorylation of these kinases by IGF-1 was not lost by G␤ knockdown (data not shown).
To examine whether the inhibitory effect of Cx43 knockdown on PI3K-Akt-GSK-3␤ signaling is specific to this signaling pathway, effects of Cx43 knockdown on responses of PKC-ε, ERK, and p38 MAP kinase were assessed. As shown in Fig. 5 , PKC-ε, ERK, and p38 MAP kinase were similarly phosphorylated by ET-1 in control and Cx43 siRNA-transfected cells. G␤ siRNA also failed to inhibit p38 MAP kinase phosphorylation by ET-1 (Fig. 5B) .
In A7r5 cells, a smooth muscle cell line, phosphorylation of Akt and that of GSK-3␤ by ET-1 was not affected by reduction of Cx43 expression (Fig. 6 ). These findings suggest that the role of Cx43 in GPCR-induced PI3K-Akt-GSK-3␤ signaling is specific to cardiomyocytes.
Effects of Cx43 knockdown on mitochondrial ROS production. As in previous studies on rabbit cardiac mitochondria (17, 24, 25), mitochondria in H9c2 cells generated ROS in response to treatment with DADLE or ET-1 (Fig. 7) . However, IGF-1 did not induce mitochondrial ROS production. In contrast to genetic partial deletion of Cx43 in mouse myocytes (15), Cx43 knockdown using siRNA did not reduce mitochondrial ROS production by activation of the mK ATP channel. By blotting for Cx43 in samples separated from those for ROS determination (n ϭ 5), we confirmed that Cx43 siRNA reduced Cx43 to 18% of controls in this series of experiments as well. ROS production in response to DADLE and ET-1 treatment was also unaffected by Cx43 knockdown.
Effects of Cx43 knockdown on cytoprotection afforded by PI3K-Akt-GSK-3␤ signaling. Exposure to 100 M H 2 O 2 for 3 h induced necrosis in 30ϳ40% of control siRNA-transfected cells. Pretreatment with DADLE and that with IGF-1 significantly reduced cell necrosis to 43 and 58% of the control, respectively (Fig. 8) . Suppression of Cx43 expression by its siRNA abolished the protection afforded by DADLE but not the protection afforded by IGF-1. Incubation with 60 M antimycin A for 3 h induced more extensive injury than did the H 2 O 2 treatment, resulting in necrosis in almost all cells in the control groups. Pretreatment with ET-1 and that with IGF-1 afforded comparable protection, reducing cell necrosis by 23 and 33%, respectively. A protective effect of ET-1 was not detected in cells in which Cx43 protein was reduced by siRNA, though the protection by IGF-1 was unaffected by Cx43 siRNA (Fig. 9) .
Effects of Cx40 and Cx45 knockdown on PI3K-Akt-GSK-3␤ signaling. Since Cx43 knockdown inhibited activation of PI3K-Akt-GSK-3␤ signaling by ET-1 (Fig. 2) , we performed a post hoc series of experiments to examine the involvement of Cx40 and Cx45 in the signaling. Cx40 siRNA reduced Cx40 protein level by 66%, but it did not inhibit phosphorylation of Akt induced by ET-1 (Fig. 10, A and B) . Since detection of Cx45 in H9c2 cells by a commercial anti-Cx45 antibody was unsuccessful, we confirmed the efficacy of Cx45 siRNA by quantitative RT-PCR (Fig.  10C) . Pretreatment with Cx45 siRNA inhibited ET-1-induced phosphorylation of Akt (Fig. 10D) .
Effects of a gap junction blocker on Cx43-mediated Akt signaling.
To examine whether the role of Cx43 in PI3K activation depends on open status of the Cx43 channel (i.e., hemichannel and/or gap junctions), we used 37, 43 GAP27, a peptide mimetic of the extracellular loop of Cx43 and Cx37. As shown in Fig. 11 , phosphorylation of Akt by ET-1 was inhibited by pretreatment with 37, 43 GAP27.
DISCUSSION
In the heart, two classes of PI3K, class I A and class I B , are responsible for Akt activation, and these classes of PI3K are coupled with different types of receptors. Cytokine receptors induce interaction of regulatory p85 subunit with catalytic p110 subunit (␣, ␤, and ␦) of class I A PI3K. In contrast, GPCRs activate class I B PI3K via G␤␥ subunit-mediated interaction of p110␥ with p84 and/or p101 (36, 37) . Interestingly, Ras can activate both of these classes of PI3K (37) . The present study showed that ϳ80% reduction of Cx43 protein abolished Akt and GSK-3␤ phosphorylation in response to activation of the ␦-opioid receptor and activation of the ET receptor, whereas responses of the same kinases to activation of the IGF-1 receptor remained unchanged. Importantly, knockdown of Cx43 did not inhibit activation of PKC-ε, ERK, and p38 MAP kinase by ET-1, indicating that reduction of Cx43 protein did not impair all signal transmission from GPCRs. In contrast to H9c2 cells, A7r5 cells showed similar responses of Akt and GSK-3␤ to activation of the ET receptor regardless of the level of Cx43 expression (Fig. 6) . Taken together, these findings suggest that Cx43 is involved in activation of class I B PI3K by GPCRs characteristically in cardiomyocytes, although Cx43 is unnecessary for class I A PI3K activation.
As a mechanism by which Cx43 contributes to activation of class I B PI3K, we postulated two possibilities: promotion of mK ATP -mediated ROS generation and enhancement of p110␥-G␤␥ interactions. Cx43 localizes in the inner membrane of subsarcolemmal mitochondria (4), and it augments mK ATP channel activity, leading to increased ROS production (15, 18, 30) . In a study by Heinzel et al. (15) using MitoTracker to determine mitochondrial ROS, production of ROS in response to treatment with diazoxide, an mK ATP channel opener, was significantly reduced in myocytes isolated from heterozygous Cx43-knockout mice. Furthermore, Rottlaender et al. (30) recently showed that diazoxide-induced K ϩ current in patch clamping of the inner membrane of mitochondria was significantly attenuated in mitochondria of heterozygous Cx43-knockout mice. We first assumed that ROS generated by mitochondria may activate Ras, an activator of PI3K, and PKC, an upstream kinase of GSK-3␤. However, mitochondrial ROS produced by diazoxide, DADLE, or ET-1 was unchanged by Cx43 siRNA, which reduced Cx43 by ϳ80% (Fig. 7) . The reason for the discrepancy between the present findings and those by Heizel et al. (15) is unclear. However, the difference in species (rat vs. mouse) or other experimental conditions might be responsible. Nevertheless, the present results indicate that Cx43 contributes to PI3K activation by a mechanism other than promotion of mitochondrial ROS production.
To the best of our knowledge, no evidence for possible involvement of Cx43 in p110␥-G␤␥ interactions has been reported. However, Cx43 in the cell membrane has been reported to interact with various signaling molecules, including P2Y1 receptor and AGS8 (12, (32) (33) (34) . In the present experiments, Cx43 was coimmunoprecipitated with G␤ in total homogenates (Fig. 4A ) and in sarcolemma-rich fractions (Fig. 4B) . Knockdown of the G␤ gene mimicked the effects of Cx43 knockdown on PI3K-Akt-GSK-3␤ signaling (Fig. 4C) . These findings support the notion that Cx43 in the sarcolemma has a permissive role for G␤ to interact with p110␥ of PI3K. Unfortunately, we failed to examine Cx43-p110␥ and G␤␥-p110␥ interactions because commercially available antip110␥ antibodies were not suitable for immunoprecipitation in our hands (data not shown).
Increase in tolerance against necrosis and apoptosis by activation of PI3K-Akt-GSK-3␤ signaling has been observed in cardiomyocytes in vitro and those in vivo (19 -23) . In the present study, we confirmed that activation of this signaling by DADLE, ET-1, or IGF-1 protects H9c2 cells from necrosis induced by oxidant stress (Figs. 8 and 9 ). Knockdown of Cx43 by siRNA attenuated PI3K-Akt-GSK-3␤ signaling by DADLE and ET-1 and eliminated cytoprotection afforded by these GPCR ligands. These findings indicate that protein level of Cx43 is a determinant of protection afforded by GPCRs coupling to class I B PI3K. In a post hoc series of experiments, we examined whether the role of Cx43 in activation of class I B PI3K is shared by Cx40 and Cx45. Knockdown of Cx40 protein expression did not inhibit Akt phosphorylation by ET-1, but Cx45 knockdown mimicked the effects of Cx43 knockdown on Akt phosphorylation. Interestingly, a recent study (29) has shown that Cx43 forms gap junction plaque with Cx45 but not with Cx40 in HeLa cells, indicating functional intimacy of Cx43 and Cx45. However, Cx45 is expressed at the early stage of heart development and is downregulated after birth (2, 3) . Thus the present finding regarding Cx45 in H9c2 cells may not be extrapolated to adult hearts in situ.
In another post hoc series of experiments, 37 ,43 GAP27, a peptide inhibitor of Cx43 and Cx37 (8) , blocked response of Akt to activation of the ET receptor (Fig. 11) . Since Cx37 is expressed in endothelial cells but not in cardiomyocytes, the results shown in Fig. 11 suggest that either transport of certain molecules through the Cx43 channel or configuration change in the channel per se contributes to activation of class I B PI3K after GPCR stimulation. However, the present data are preliminary, and the relationship between functional status of the Cx43 channel and class I B PI3K remains unclear.
The present observations carry some clinical implications. Cardiac tissue samples from heart failure patients and animal models of heart failure showed reduction, redistribution, and/or increased heterogeneity of Cx43 expression in cardiomyocytes (1, 7, 16, 35) . These changes in Cx43 expression have been discussed as possible underlying mechanisms of ventricular arrhythmias and dyssynchrony (5, 39) . However, the present results raise the possibility that some of the known modifications of signaling pathways downstream of GPCRs in failing hearts (10, 26) are attributable to insufficient level of Cx43 in the sarcolemma. Nevertheless, roles of the Cx43 hemichannel in signal transduction and its interaction with signaling molecules may warrant further investigation.
There are limitations in this study. We cannot exclude the possibility that Cx43 in mitochondria contributes to class I B PI3K activation by a mechanism independent of ROS production. However, no signaling molecule other than ROS has been shown to be regulated by Cx43 in mitochondrial inner membranes. To examine the involvement of mitochondrial Cx43 in PI3K activation, we attempted to inhibit recruitment of cytosolic Cx43 to mitochondria by using geldanamycin, an HSP90 inhibitor. Unfortunately, our attempt was unsuccessful since treatment of H9c2 cells with 0.1ϳ9 M of geldanamycin for 4ϳ24 h failed to significantly reduce Cx43 in the mitochondrial fraction without cytotoxicity. It is also unclear whether Cx43-PI3K interaction is modified by phosphorylation of Cx43 at Ser and/or Tyr residues.
In conclusion, the present study suggests that Cx43 is required for activation of class I B PI3K by GPCRs, possibly as a cofactor of G␤, leading to Akt-GSK-3␤-mediated protection against necrosis in cardiomyocytes.
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